Evidence map›Paper›PMID 40817696›Full record

ArticleBiotechnology and bioengineering2025

Development of a Small-Scale Continuous Virus Filtration Model That Incorporates Inline Spiking and Mixing.

Ioana Pintescu, Julie Kozaili, Daniel Strauss

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ioana PintescuAsahi Kasei Bioprocess America, Inc, Glenview, Illinois, USA.ORCID https://orcid.org/0009-0000-5250-0793
Julie KozailiAsahi Kasei Bioprocess America, Inc, Glenview, Illinois, USA.ORCID https://orcid.org/0000-0003-3552-0383
Daniel StraussAsahi Kasei Bioprocess America, Inc, Glenview, Illinois, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent efforts have focused on shifting biomanufacturing from traditional batch mode processing to continuous processing as these technologies have the potential to increase productivity and product quality. However, the lack of a unified methodology for viral clearance validation of virus filtration (VF) in continuous processing has presented a hurdle to its implementation. Through the use of spiking a concentrated virus stock into a continuous filtration system, product flow with a stable virus level can be supplied to the filter over a long duration to allow uninterrupted flow and achieve viral clearance validation conditions comparable to those of traditional batch spiking for batch processing. In this study, we developed a small-scale inline virus spiking and mixing model as a proposed validation strategy for a connected, continuous chromatography and VF system operated in constant flow mode over long durations and with high throughputs. The small-scale model was successfully operated for upwards of 72 h and produced the expected virus-spiked product feed solutions with no deviation in virus, protein and buffer concentrations throughout the runs. In addition, laboratory-scale Planova BioEX filters showed complete removal of porcine parvovirus with a logarithmic reduction value greater than 5.5 when run continuously for 72 h.

Indexed as

FiltrationParvovirus, PorcineVirusesAnimalscontinuous virus removal filtrationinline spiking and mixingviral clearance

Identifiers

PMID40817696
PMCPMC12503011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.